Core Viewpoint - Institutional investors in Snowflake Inc. (NYSE: SNOW) are encouraged to evaluate lead plaintiff opportunities in a pending securities class action due to significant stock price declines attributed to misleading statements by the company [1][3]. Institutional Investor Impact - Snowflake has over 334 million shares outstanding, and the stock price fell by $41.72 per share, or 18.14%, following corrective disclosures on February 28, 2024 [2]. - The lawsuit claims that Snowflake and its officers made materially misleading statements regarding consumption patterns and revenue growth, impacting institutional investors who held shares during the class period [3][6]. Fiduciary Obligations - Fiduciaries are required to assess legal remedies when portfolio holdings experience losses due to alleged securities fraud, with the opportunity to serve as lead plaintiff allowing for selection of counsel and oversight of litigation strategy [5]. - The PSLRA favors institutional investors with the largest financial interest in the relief sought, and absent class members can still participate in recovery without being lead plaintiffs [5]. Portfolio Impact Assessment - The lawsuit alleges that Snowflake's stock price was artificially inflated by positive statements about consumption and revenue targets, which were later revised downwards, leading to a significant impact on institutional holders [6].

Core Viewpoint - Institutional investors holding Snowflake Inc. (NYSE: SNOW) shares from June 27, 2023, to February 28, 2024, may face portfolio losses due to alleged securities fraud, prompting a potential class action lawsuit [1] Summary by Relevant Sections Institutional Holders - The stock price of Snowflake declined by $41.72 per share, or 18.14%, following corrective disclosures on February 28, 2024 [1] - The lawsuit claims that Snowflake and its officers made materially misleading statements regarding consumption patterns, product revenue growth, and the feasibility of a $10 billion revenue target for 2029 [1] - Institutional investors are encouraged to assess their options for recovery before the April 27, 2026, deadline for lead plaintiff appointment [1] Portfolio Impact Assessment - The lawsuit alleges that Snowflake's stock was artificially inflated due to positive statements about consumption stability and new product developments [1] - The company disclosed that FY '25 product revenue growth would only reach 22% year-over-year, significantly below the anticipated 30%, and withdrew its $10 billion target for 2029, leading to a repricing that affected all institutional holders who bought shares based on previous representations [1]